Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Biol Psychiatry. 2019 Jun 29;87(1):74–81. doi: 10.1016/j.biopsych.2019.06.017

Table 2.

Analgesic Target Clinical Failures

NK1 - substance P/tachykinin receptor antagonist
TRPV1 - noxious heat/proton/capsaicin transducer antagonist
Nav1.7 - voltage-gated sodium channel blocker/nociceptor excitability
Cav3.2 - calcium channel blocker/synaptic transmission
Kv7 - potassium channel opener/nociceptor excitability
FAAH1 - enzyme inhibitor- cannabinoid enhancer
CB1/CB2 - cannabinoid receptors agonists
α2 adrenergic receptor inhibitor
p38 - intracellular kinase inhibitor
CCR2 - chemokine antagonist